{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T11:04:10Z","timestamp":1768907050394,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Austrian Science Fund (FWF): DOC 129-B","award":["10.55776\/KLI1153"],"award-info":[{"award-number":["10.55776\/KLI1153"]}]},{"name":"Austrian Science Fund (FWF): DOC 129-B","award":["10.55776\/KLI1153"],"award-info":[{"award-number":["10.55776\/KLI1153"]}]},{"name":"Austrian Science Fund (FWF): DOC 129-B","award":["10.55776\/KLI1153"],"award-info":[{"award-number":["10.55776\/KLI1153"]}]},{"DOI":"10.13039\/100015330","name":"Max Kade Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Austrian Society of Pulmonology"},{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The pulmonary vascular involvement of COPD ranges from severe airway obstruction without pulmonary hypertension (PH) to mild airway obstruction with severe PH. Iron-dependent molecular regulators like hypoxia-inducible factor-2 (HIF-2) may contribute to these phenotypic variations. We explored the role of soluble transferrin receptor-1 (sTfR1) for diagnosis and prognosis of PH associated with COPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed COPD outpatients who underwent right heart catheterization and performed unsupervised clustering analysis based on sTfR1 levels and non-invasive clinical parameters to identify specific COPD phenotypes. Additionally, we examined explanted end-stage COPD lungs for TfR1 expression and iron deposition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      sTfR1 was associated with mean pulmonary artery pressure (mPAP) (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.45,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), pulmonary vascular resistance (PVR) (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.395,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and poor survival. sTfR1 predicted severe PH (AUROC [95% CI], 0.72 [0.61\u20130.83]), and AUROC was further improved based on a combination of sTfR1 and low hemoglobin (0.82 [0.73\u20130.92]). sTfR1-based cluster analysis distinguished three COPD phenotypes with significantly different survival. One of the two clusters with poor survival was characterized by moderate airway obstruction and moderate PH but elevated sTfR1, anemia and inflammation. In explanted COPD lungs, TfR1-positive and iron-laden cells, most likely, consisted of macrophages, and iron-loaded cell density was negatively correlated with mPAP in patients with moderate\/severe PH (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u00a00.681,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.015).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated sTfR1 predicts poor prognosis in patients with COPD and, particularly in combination with low hemoglobin, may serve as a biomarker for severe PH in COPD, identifying a distinct phenotype with systemic inflammation, anemia and iron deficiency.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00408-025-00833-3","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:13:15Z","timestamp":1752505995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Soluble Transferrin Receptor-1 in Pulmonary Hypertension Associated with COPD"],"prefix":"10.1007","volume":"203","author":[{"given":"Oleh","family":"Myronenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pero","family":"Curcic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Douschan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Zeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Suessner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Hoetzenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Olschewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horst","family":"Olschewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasile","family":"Foris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"833_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","volume":"4","author":"MM Hoeper","year":"2016","unstructured":"Hoeper MM, Humbert M, Souza R, Idrees M, Kawut SM, Sliwa-Hahnle K, Jing Z-C, Gibbs JSR (2016) A global view of pulmonary hypertension. Lancet Respir Med 4:306\u2013322","journal-title":"Lancet Respir Med"},{"key":"833_CR2","doi-asserted-by":"publisher","first-page":"39S","DOI":"10.1378\/chest.10-0087","volume":"137","author":"OA Minai","year":"2010","unstructured":"Minai OA, Chaouat A, Adnot S (2010) Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest 137:39S-51S","journal-title":"Chest"},{"key":"833_CR3","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2147\/COPD.S359873","volume":"17","author":"L Zhang","year":"2022","unstructured":"Zhang L, Liu Y, Zhao S et al (2022) The incidence and prevalence of pulmonary hypertension in the COPD population: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 17:1365\u20131379","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"833_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01200-2024","author":"OA Shlobin","year":"2024","unstructured":"Shlobin OA, Adir Y, Barbera JA, Cottin V, Harari S, Jutant E-M, Pepke-Zaba J, Ghofrani H-A, Channick R (2024) Pulmonary hypertension associated with lung diseases. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01200-2024","journal-title":"Eur Respir J"},{"key":"833_CR5","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00716-2024","author":"M Steger","year":"2024","unstructured":"Steger M, Canuet M, Martin G et al (2024) Pulmonary hypertension associated with COPD: a phenotype analysis. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00716-2024","journal-title":"ERJ Open Res"},{"key":"833_CR6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01633-2023","author":"J Weatherald","year":"2024","unstructured":"Weatherald J, Hemnes AR, Maron BA, Mielniczuk LM, Gerges C, Price LC, Hoeper MM, Humbert M (2024) Phenotypes in pulmonary hypertension. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01633-2023","journal-title":"Eur Respir J"},{"key":"833_CR7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00944-2021","author":"K Zeder","year":"2021","unstructured":"Zeder K, Avian A, Bachmaier G et al (2021) Elevated pulmonary vascular resistance predicts mortality in COPD patients. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.00944-2021","journal-title":"Eur Respir J"},{"key":"833_CR8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00879-2022","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM et al (2022) 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.00879-2022","journal-title":"Eur Respir J"},{"key":"833_CR9","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0173-2022","author":"O Myronenko","year":"2023","unstructured":"Myronenko O, Foris V, Crnkovic S, Olschewski A, Rocha S, Nicolls MR, Olschewski H (2023) Endotyping COPD: hypoxia-inducible factor-2 as a molecular \u201cswitch\u201d between the vascular and airway phenotypes? Eur Respir Rev. https:\/\/doi.org\/10.1183\/16000617.0173-2022","journal-title":"Eur Respir Rev"},{"key":"833_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1164\/rccm.202001-0078OC","volume":"202","author":"S Pasupneti","year":"2020","unstructured":"Pasupneti S, Tian W, Tu AB et al (2020) Endothelial HIF-2\u03b1 as a key endogenous mediator preventing emphysema. Am J Respir Crit Care Med 202:983\u2013995","journal-title":"Am J Respir Crit Care Med"},{"key":"833_CR11","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/cdd.2008.17","volume":"15","author":"SA Patel","year":"2008","unstructured":"Patel SA, Simon MC (2008) Biology of hypoxia-inducible factor-2\u03b1 in development and disease. Cell Death Differ 15:628\u2013634","journal-title":"Cell Death Differ"},{"key":"833_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2466-14-24","volume":"14","author":"DS Silverberg","year":"2014","unstructured":"Silverberg DS, Mor R, Weu MT, Schwartz D, Schwartz IF, Chernin G (2014) Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulm Med 14:24","journal-title":"BMC Pulm Med"},{"key":"833_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.chest.2021.07.2159","volume":"161","author":"J Tatah","year":"2022","unstructured":"Tatah J, Keen JL, Prisco SZ, Pritzker M, Thenappan T, Prins KW (2022) Iron deficiency is associated with more severe pulmonary vascular disease in pulmonary hypertension caused by chronic lung disease. Chest 161:232\u2013236","journal-title":"Chest"},{"key":"833_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/eurheartj\/ehac569","volume":"44","author":"G Savarese","year":"2023","unstructured":"Savarese G, von Haehling S, Butler J, Cleland JGF, Ponikowski P, Anker SD (2023) Iron deficiency and cardiovascular disease. Eur Heart J 44:14\u201327","journal-title":"Eur Heart J"},{"key":"833_CR15","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.1038\/s41598-019-46471-7","volume":"9","author":"N Najafinobar","year":"2019","unstructured":"Najafinobar N, Venkatesan S, von Sydow L, Klarqvist M, Olsson H, Zhou X-H, Cloonan SM, Malmberg P (2019) ToF-SIMS mediated analysis of human lung tissue reveals increased iron deposition in COPD (GOLD IV) patients. Sci Rep 9:10060","journal-title":"Sci Rep"},{"key":"833_CR16","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1093\/eurheartj\/ehad149","volume":"44","author":"P Martens","year":"2023","unstructured":"Martens P, Yu S, Larive B et al (2023) Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications. Eur Heart J 44:1979\u20131991","journal-title":"Eur Heart J"},{"key":"833_CR17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.beem.2015.09.003","volume":"29","author":"K Harms","year":"2015","unstructured":"Harms K, Kaiser T (2015) Beyond soluble transferrin receptor: old challenges and new horizons. Best Pract Res Clin Endocrinol Metab 29:799\u2013810","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"833_CR18","doi-asserted-by":"publisher","first-page":"11911","DOI":"10.1038\/s41598-022-15674-w","volume":"12","author":"M Kang","year":"2022","unstructured":"Kang M, Kwon S, Lee W et al (2022) Soluble transferrin receptor can predict all-cause mortality regardless of anaemia and iron storage status. Sci Rep 12:11911","journal-title":"Sci Rep"},{"key":"833_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cell.2024.10.045","volume":"188","author":"Y-T Deng","year":"2025","unstructured":"Deng Y-T, You J, He Y et al (2025) Atlas of the plasma proteome in health and disease in 53026 adults. Cell 188:253-271.e7","journal-title":"Cell"},{"key":"833_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1164\/rccm.201401-0037OC","volume":"190","author":"J Hoffmann","year":"2014","unstructured":"Hoffmann J, Wilhelm J, Marsh LM, Ghanim B, Klepetko W, Kovacs G, Olschewski H, Olschewski A, Kwapiszewska G (2014) Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension. Am J Respir Crit Care Med 190:98\u2013111","journal-title":"Am J Respir Crit Care Med"},{"key":"833_CR21","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1378\/chest.97.6.1367","volume":"97","author":"K Kondo","year":"1990","unstructured":"Kondo K, Noguchi M, Mukai K, Matsuno Y, Sato Y, Shimosato Y, Monden Y (1990) Transferrin receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosis. Chest 97:1367\u20131371","journal-title":"Chest"},{"key":"833_CR22","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA et al (2017) QuPath: op en source software for digital pathology image analysis. Sci Rep 7:16878","journal-title":"Sci Rep"},{"key":"833_CR23","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.amjcard.2009.05.016","volume":"104","author":"CV Hampole","year":"2009","unstructured":"Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ (2009) Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension\u2020. Am J Cardiol 104:868\u2013872","journal-title":"Am J Cardiol"},{"key":"833_CR24","first-page":"e3853454","volume":"2019","author":"J Yang","year":"2019","unstructured":"Yang J, Liu C, Li L, Tu X, Lu Z (2019) Red blood cell distribution width predicts pulmonary hypertension sary to chronic obstructive pulmonary disease. Can Respir J 2019:e3853454","journal-title":"Can Respir J"},{"key":"833_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/bph.14979","volume":"178","author":"M Gredic","year":"2021","unstructured":"Gredic M, Blanco I, Kovacs G, Helyes Z, Ferdinandy P, Olschewski H, Barber\u00e0 JA, Weissmann N (2021) Pulmonary hypertension in chronic obstructive pulmonary disease. Br J Pharmacol 178:132\u2013151","journal-title":"Br J Pharmacol"},{"key":"833_CR26","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S2213-2600(23)00264-3","volume":"11","author":"M Humbert","year":"2023","unstructured":"Humbert M, Sitbon O, Guignabert C, Savale L, Boucly A, Gallant-Dewavrin M, McLaughlin V, Hoeper MM, Weatherald J (2023) Treatment of pulmonary arterial hypertension: recent progress and a look to the future. Lancet Respir Med 11:804\u2013819","journal-title":"Lancet Respir Med"},{"key":"833_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.chest.2022.01.031","volume":"162","author":"G Kovacs","year":"2022","unstructured":"Kovacs G, Avian A, Bachmaier G et al (2022) Severe pulmonary hypertension in COPD: impact on survival and diagnostic approach. Chest 162:202\u2013212","journal-title":"Chest"},{"key":"833_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1378\/chest.12-1246","volume":"144","author":"V Foris","year":"2013","unstructured":"Foris V, Kovacs G, Tscherner M, Olschewski A, Olschewski H (2013) Biomarkers in pulmonary hypertension: what do we know? Chest 144:274\u2013283s","journal-title":"Chest"},{"key":"833_CR29","doi-asserted-by":"publisher","first-page":"1802460","DOI":"10.1183\/13993003.02460-2018","volume":"53","author":"JM Leung","year":"2019","unstructured":"Leung JM, Obeidat M, Sadatsafavi M, Sin DD (2019) Introduction to precision medicine in COPD. Eur Respir J 53:1802460","journal-title":"Eur Respir J"},{"key":"833_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","volume":"25","author":"B Galy","year":"2024","unstructured":"Galy B, Conrad M, Muckenthaler M (2024) Mechanisms controlling cellular and systemic iron homeostasis. Nat Rev Mol Cell Biol 25:133\u2013155","journal-title":"Nat Rev Mol Cell Biol"},{"key":"833_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0009-8981(03)00005-6","volume":"329","author":"Y Beguin","year":"2003","unstructured":"Beguin Y (2003) Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 329:9\u201322","journal-title":"Clin Chim Acta"},{"key":"833_CR32","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1165\/rcmb.2018-0239OC","volume":"62","author":"K Sato","year":"2020","unstructured":"Sato K, Inoue S, Igarashi A et al (2020) Effect of iron deficiency on a murine model of smoke-induced emphysema. Am J Respir Cell Mol Biol 62:588\u2013597","journal-title":"Am J Respir Cell Mol Biol"},{"key":"833_CR33","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1161\/CIRCRESAHA.116.305265","volume":"116","author":"E Cotroneo","year":"2015","unstructured":"Cotroneo E, Ashek A, Wang L, Wharton J, Dubois O, Bozorgi S, Busbridge M, Alavian KN, Wilkins MR, Zhao L (2015) Iron homeostasis and pulmonary hypertension. Circ Res 116:1680\u20131690","journal-title":"Circ Res"},{"key":"833_CR34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.toxlet.2018.07.010","volume":"295","author":"SR Bertoli","year":"2018","unstructured":"Bertoli SR, Marques VB, Rossi EM, Krause M, Carneiro MTWD, Sim\u00f5es MR, dos Santos L (2018) Chronic iron overload induces vascular dysfunction in resistance pulmonary arteries associated with right ventricular remodeling in rats. Toxicol Lett 295:296\u2013306","journal-title":"Toxicol Lett"},{"key":"833_CR35","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1001\/jama.2009.1404","volume":"302","author":"TG Smith","year":"2009","unstructured":"Smith TG, Talbot NP, Privat C, Rivera-Ch M, Nickol AH, Ratcliffe PJ, Dorrington KL, Le\u00f3n-Velarde F, Robbins PA (2009) Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. JAMA 302:1444","journal-title":"JAMA"},{"key":"833_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1113\/EP091078","volume":"108","author":"JP Hartmann","year":"2023","unstructured":"Hartmann JP, Bailey DM, Berg RMG (2023) A song of iron and oxygen: hypoxic pulmonary vasoconstriction and gas exchange in chronic obstructive pulmonary disease. Exp Physiol 108:535\u2013538","journal-title":"Exp Physiol"},{"key":"833_CR37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/ajh\/hpv163","volume":"29","author":"Y Naito","year":"2016","unstructured":"Naito Y, Hosokawa M, Sawada H et al (2016) Transferrin receptor 1 in chronic hypoxia-induced pulmonary vascular remodeling. Am J Hypertens 29:713\u2013718","journal-title":"Am J Hypertens"},{"key":"833_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12950-017-0160-9","volume":"14","author":"T Schepens","year":"2017","unstructured":"Schepens T, De Dooy JJ, Verbrugghe W, Jorens PG (2017) Red cell distribution width (RDW) as a biomarker for respiratory failure in a pediatric ICU. J Inflamm 14:12","journal-title":"J Inflamm"},{"key":"833_CR39","first-page":"385","volume":"119","author":"BJ Ferguson","year":"1992","unstructured":"Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD (1992) Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 119:385\u2013390","journal-title":"J Lab Clin Med"},{"key":"833_CR40","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jacc.2011.02.057","volume":"58","author":"CJ Rhodes","year":"2011","unstructured":"Rhodes CJ, Howard LS, Busbridge M, Ashby D, Kondili E, Gibbs JSR, Wharton J, Wilkins MR (2011) iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 58:300\u2013309","journal-title":"J Am Coll Cardiol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-025-00833-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-025-00833-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-025-00833-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T04:42:34Z","timestamp":1766378554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-025-00833-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1007\/s00408-025-00833-3","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest relevant to the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"79"}}